Evidence map›Paper›PMID 35610250›Full record

ArticleScientific reports2022

COVID-19 pandemic influence on self-reported health status and well-being in a society.

Anna Moniuszko-Malinowska, Piotr Czupryna, Marlena Dubatówka, Magda Łapińska, Małgorzata Kazberuk, Aleksandra Szum-Jakubowska, Sebastian Sołomacha, Paweł Sowa, Łukasz Kiszkiel, Łukasz Szczerbiński and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Anna Moniuszko-Malinowska *Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Zurawia 14, 15-540, Bialystok, Poland. anna.moniuszko-malinowska@umb.edu.pl.
Piotr Czupryna *Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Zurawia 14, 15-540, Bialystok, Poland.
Marlena DubatówkaDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269, Bialystok, Poland.
Magda ŁapińskaDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269, Bialystok, Poland.
Małgorzata KazberukMedical University of Bialystok, Bialystok, Poland.
Aleksandra Szum-JakubowskaDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269, Bialystok, Poland.
Sebastian SołomachaDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269, Bialystok, Poland.
Paweł SowaDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269, Bialystok, Poland.
Łukasz KiszkielSociety and Cognition Unit, University of Bialystok, 15-403, Bialystok, Poland.
Łukasz SzczerbińskiDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, 15-276, Bialystok, Poland.
Anna BukłahaDepartment of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Zurawia 14, 15-540, Bialystok, Poland.
Piotr Paweł Laskowski *Society and Cognition Unit, University of Bialystok, 15-403, Bialystok, Poland.
Karol Adam KamińskiDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269, Bialystok, Poland.
Medical University of Białystok · PLUniversity of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the frequency of persisting symptoms after SARS-CoV-2 infection and assessment of the effects of COVID-19 pandemic on selected parameters of self-reported health status and well-being half a year after the disease. The study population consisted of 3 groups: post-COVID-19 group I-172 patients; group II-172 patients with chronic disease, who have not suffered from COVID-19; group III-81 patients from a population study cohort-Bialystok PLUS. A standardized interview questionnaire was used to collect data in the three groups using the CATI (computer assisted telephone interviewing) technique. Interviews were conducted between October 2020 and January 2021, thus during the second wave of the pandemic in Poland. The subjective state of health in comparison with the state of health before the COVID-19 pandemic deteriorated in COVID-19 convalescents. Patients, who suffered from symptomatic COVID-19 were more prone to nervousness, anxiousness, tension than patients with oligosymptomatic course of the disease. Moreover, anxiety, fear and irritability were more frequent in Group I and II in comparison to Group III, whereas Group I and II did not differ significantly. The decrease in physical activity observed in COVID-19 patients mirrored the changes in general population. The most frequent persistent symptoms after COVID-19 are: general malaise, cough, smell and taste disorder, dyspnea. COVID-19 convalescents who experienced symptomatic disease are more prone to development of nervousness, anxiousness, tension and anxiety than patients with oligosymptomatic course of the disease. Females and younger patients who suffered from COVID-19 are more prone to development of mental distress than healthy population. No significant differences between COVID-19 convalescents and healthy population was observed as far as the attitude towards physical activity is concerned.

Indexed as

COVID-19AnxietyDepressionFemaleHealth StatusHumansPandemicsSARS-CoV-2Self Report

Identifiers

PMID35610250
PMCPMC9128771
OpenAlexW4282946514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.